Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation

scientific article published on 26 September 2020

Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HON.2813
P698PubMed publication ID32979278

P50authorThomas PabstQ88968838
Ulrike BacherQ91390715
P2093author name stringYara Banz
Behrouz Mansouri Taleghani
Stefan Zimmerli
Myriam Legros
Christophe Betticher
P2860cites workAcute Phase Reactants in Infections: Evidence-Based Review and a Guide for CliniciansQ26799899
Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patientsQ33499065
Engraftment syndrome following hematopoietic stem cell transplantationQ34298239
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management ApproachQ36264701
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeQ36575315
Engraftment syndrome: double-edged sword of hematopoietic cell transplantsQ38315390
Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospectsQ38568355
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients.Q39067361
Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacyQ39295929
Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipientsQ40424504
Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survivalQ40505136
Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infectionQ40517545
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteriaQ40563612
Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survivalQ40596090
Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single centerQ43198285
NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myelomaQ47743476
Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patientsQ48171542
Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML.Q53980398
Current status of autologous stem cell transplantation for multiple myelomaQ64065748
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantationQ88506851
A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patientsQ90665234
Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myelomaQ90925676
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsQ90960519
Engraftment Syndrome: Clinical Features and Predictive Factors in Autologous Stem Cell TransplantQ91049552
Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemiaQ91657523
High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patientsQ92488819
Autologous stem cell transfusions on multiple days in patients with multiple myeloma-Does it matter?Q93097513
P921main subjectstem cell transplantationQ65592366
P577publication date2020-09-26
P1433published inHematological OncologyQ15762617
P1476titleProphylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation

Search more.